Role of LIGHT in the pathogenesis of joint destruction in rheumatoid arthritis
- PMID: 28589079
- PMCID: PMC5439172
- DOI: 10.5493/wjem.v7.i2.49
Role of LIGHT in the pathogenesis of joint destruction in rheumatoid arthritis
Abstract
Aim: To characterise the role of substitutes for receptor-activator nuclear factor kappa-B ligand (RANKL) in rheumatoid arthritis (RA) joint destruction.
Methods: Synovial fluid (SF) macrophages isolated from the knee joint of RA patients were incubated with 25 ng/mL macrophage-colony stimulating factor (M-CSF) and 50 ng/mL LIGHT (lymphotoxin-like, exhibits inducible expression and competes with herpes simplex virus glycoprotein D for herpes virus entry mediator, a receptor expressed by T lymphocytes) in the presence and absence of 25 ng/mL RANKL and 100 ng/mL osteoprotegerin (OPG) on glass coverslips and dentine slices. Osteoclastogenesis was assessed by the formation of multinucleated cells (MNCs) expressing tartrate-resistant acid phosphatase (TRAP) on coverslips and the extent of lacunar resorption pit formation on dentine slices. The concentration of LIGHT in RA and osteoarthritis (OA) synovial fluid was measured by an enzyme-linked immunosorbent assay (ELISA) and the expression of LIGHT in RA and OA synovium was determined by immunohistochemistry using an indirect immunoperoxidase technique.
Results: In cultures of RA SF macrophages treated with LIGHT and M-CSF, there was significant formation of TRAP + MNCs on coverslips and extensive lacunar resorption pit formation on dentine slices. SF-macrophage-osteoclast differentiation was not inhibited by the addition of OPG, a decoy receptor for RANKL. Resorption pits were smaller and less confluent than in RANKL-treated cultures but the overall percentage area of the dentine slice resorbed was comparable in LIGHT- and RANKL-treated cultures. LIGHT significantly stimulated RANKL-induced lacunar resorption compared with RA SF macrophages treated with either RANKL or LIGHT alone. LIGHT was strongly expressed by synovial lining cells, subintimal macrophages and endothelial cells in RA synovium and the concentration of LIGHT was much higher in RA compared with OA SF.
Conclusion: LIGHT is highly expressed in RA synovium and SF, stimulates RANKL-independent/dependent osteoclastogenesis from SF macrophages and may contribute to marginal erosion formation.
Keywords: LIGHT; Osteoclast; Receptor-activator nuclear factor kappa-B ligand; Resorption; Rheumatoid arthritis.
Conflict of interest statement
Conflict-of-interest statement: To the best of our knowledge, no conflict of interest exists.
Figures




Similar articles
-
Synovial fluid macrophages are capable of osteoclast formation and resorption.J Pathol. 2006 Jan;208(1):35-43. doi: 10.1002/path.1891. J Pathol. 2006. PMID: 16278818
-
Rheumatoid and pyrophosphate arthritis synovial fibroblasts induce osteoclastogenesis independently of RANKL, TNF and IL-6.J Autoimmun. 2012 Dec;39(4):369-76. doi: 10.1016/j.jaut.2012.06.001. Epub 2012 Aug 3. J Autoimmun. 2012. PMID: 22867712 Free PMC article.
-
Synovial macrophage-osteoclast differentiation in inflammatory arthritis.Ann Rheum Dis. 2002 Oct;61(10):916-21. doi: 10.1136/ard.61.10.916. Ann Rheum Dis. 2002. PMID: 12228163 Free PMC article.
-
Involvement of receptor activator of NFkappaB ligand and tumor necrosis factor-alpha in bone destruction in rheumatoid arthritis.Bone. 2002 Feb;30(2):340-6. doi: 10.1016/s8756-3282(01)00682-2. Bone. 2002. PMID: 11856640 Review.
-
[Role of tumor necrosis factor family ligands in the pathogenesis of rheumatoid arthritis--new therapeutical opportunities].Pol Merkur Lekarski. 2007 Apr;22(130):300-4. Pol Merkur Lekarski. 2007. PMID: 17684931 Review. Polish.
Cited by
-
Benzylideneacetophenone Derivative Alleviates Arthritic Symptoms via Modulation of the MAPK Signaling Pathway.Molecules. 2020 Jul 22;25(15):3319. doi: 10.3390/molecules25153319. Molecules. 2020. PMID: 32707885 Free PMC article.
-
Targeting thymidine phosphorylase as a potential therapy for bone loss associated with periprosthetic osteolysis.Bioeng Transl Med. 2021 Jun 8;6(3):e10232. doi: 10.1002/btm2.10232. eCollection 2021 Sep. Bioeng Transl Med. 2021. PMID: 34589604 Free PMC article.
-
Phytoceramide Alleviates the Carrageenan/Kaolin-Induced Arthritic Symptoms by Modulation of Inflammation.Biomol Ther (Seoul). 2023 Sep 1;31(5):536-543. doi: 10.4062/biomolther.2023.031. Epub 2023 Jun 29. Biomol Ther (Seoul). 2023. PMID: 37381800 Free PMC article.
-
Signalling and putative therapeutic molecules on the regulation of synoviocyte signalling in rheumatoid arthritis.Bone Joint Res. 2021 Apr;10(4):285-297. doi: 10.1302/2046-3758.104.BJR-2020-0331.R1. Bone Joint Res. 2021. PMID: 33890482 Free PMC article.
References
-
- Symmons D, Turner G, Webb R, Asten P, Barrett E, Lunt M, Scott D, Silman A. The prevalence of rheumatoid arthritis in the United Kingdom: new estimates for a new century. Rheumatology (Oxford) 2002;41:793–800. - PubMed
-
- Fujikawa Y, Quinn JM, Sabokbar A, McGee JO, Athanasou NA. The human osteoclast precursor circulates in the monocyte fraction. Endocrinology. 1996;137:4058–4060. - PubMed
-
- Faust J, Lacey DL, Hunt P, Burgess TL, Scully S, Van G, Eli A, Qian Y, Shalhoub V. Osteoclast markers accumulate on cells developing from human peripheral blood mononuclear precursors. J Cell Biochem. 1999;72:67–80. - PubMed
-
- Lacey DL, Timms E, Tan HL, Kelley MJ, Dunstan CR, Burgess T, Elliott R, Colombero A, Elliott G, Scully S, et al. Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell. 1998;93:165–176. - PubMed
-
- Yasuda H, Shima N, Nakagawa N, Yamaguchi K, Kinosaki M, Mochizuki S, Tomoyasu A, Yano K, Goto M, Murakami A, et al. Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL. Proc Natl Acad Sci USA. 1998;95:3597–3602. - PMC - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials